Lite Strategy, Inc. Cost of Services (Deprecated 2018-01-31)
Lite Strategy, Inc. (LITS) reported Cost of Services (Deprecated 2018-01-31) of $3.38 million for the 12-month period ending 2018-06-30, per its 10-K filed 2018-08-30.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2018-08-30
- Lite Strategy, Inc. cost of services (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $1.11M, a 12.04% increase year-over-year.
- Lite Strategy, Inc. cost of services (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $930.00K, a 18.92% decline year-over-year.
- Lite Strategy, Inc. cost of services (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $728.00K, a 58.89% decline year-over-year.
- Lite Strategy, Inc. cost of services (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $618.00K, a 43.51% decline year-over-year.
- Lite Strategy, Inc. cost of services (deprecated 2018-01-31) for fiscal 2018 was $3.38M, a 32.34% decline from fiscal 2017.
- Lite Strategy, Inc. cost of services (deprecated 2018-01-31) for fiscal 2017 was $5.00M.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | $2.04M derived: sum of 2 quarters · filed 2018-08-30 | $2.77M derived: sum of 3 quarters · filed 2018-08-30 | $3.38M 10-K · filed 2018-08-30 |
| 2018-03-31 | $930.00K 10-Q · filed 2018-05-09 | $1.66M derived: sum of 2 quarters · filed 2018-05-09 | $2.28M 10-Q · filed 2018-05-09 | $3.26M derived: sum of 4 quarters · filed 2018-08-30 |
| 2017-12-31 | $728.00K 10-Q · filed 2018-02-08 | $1.35M 10-Q · filed 2018-02-08 | $2.33M derived: sum of 3 quarters · filed 2018-08-30 | $3.48M derived: sum of 4 quarters · filed 2018-08-30 |
| 2017-09-30 | $618.00K 10-Q · filed 2017-11-08 | $1.61M derived: sum of 2 quarters · filed 2018-08-30 | $2.75M derived: sum of 3 quarters · filed 2018-08-30 | $4.52M derived: sum of 4 quarters · filed 2018-08-30 |
| 2017-06-30 | $988.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | $2.13M derived: sum of 2 quarters · filed 2018-08-30 | $3.91M derived: sum of 3 quarters · filed 2018-08-30 | $5.00M 10-K · filed 2018-08-30 |
| 2017-03-31 | $1.15M 10-Q · filed 2018-05-09 | $2.92M derived: sum of 2 quarters · filed 2018-05-09 | $4.01M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $1.77M 10-Q · filed 2018-02-08 | $2.87M 10-Q · filed 2018-02-08 | ||
| 2016-09-30 | $1.09M 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |